Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Tangible Net Worth Ratio
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Tangible Net Worth Ratio of 90.7% as of June 2025. This metric is calculated by deducting intangible assets (CN¥301.86 Million) from net assets (CN¥3.24 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Zhejiang Huakang Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Huakang Pharmaceutical Co Ltd Tangible Net Worth Ratio (2016–2024)
This chart shows how Zhejiang Huakang Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 90.7%, reflecting net assets of CN¥3.24 Billion with intangible assets of CN¥301.86 Million CNY. Also explore how fast is Zhejiang Huakang Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Huakang Pharmaceutical Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 605077 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.6% | CN¥3.26 Billion | CN¥305.87 Million | CN¥6.99 Billion | ▼ -0.3 pp |
| 2023 | 90.9% | CN¥3.10 Billion | CN¥282.65 Million | CN¥6.18 Billion | ▲ +0.0 pp |
| 2022 | 90.9% | CN¥2.66 Billion | CN¥242.46 Million | CN¥3.91 Billion | ▼ -5.4 pp |
| 2021 | 96.3% | CN¥2.43 Billion | CN¥90.06 Million | CN¥3.00 Billion | ▲ +2.2 pp |
| 2020 | 94.1% | CN¥939.52 Million | CN¥55.19 Million | CN¥1.43 Billion | ▲ +2.4 pp |
| 2019 | 91.7% | CN¥684.81 Million | CN¥56.59 Million | CN¥1.15 Billion | ▼ -1.2 pp |
| 2018 | 92.9% | CN¥440.92 Million | CN¥31.33 Million | CN¥1.05 Billion | ▲ +7.9 pp |
| 2017 | 85.0% | CN¥187.99 Million | CN¥28.25 Million | CN¥702.16 Million | ▲ +10.9 pp |
| 2016 | 74.0% | CN¥136.09 Million | CN¥35.35 Million | CN¥682.12 Million | — |